These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1111276)

  • 21. Investigations of the lupus-like inhibitor by-passing activity of platelets.
    Howard MA; Firkin BG
    Thromb Haemost; 1983 Dec; 50(4):775-9. PubMed ID: 6420922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STUDIES ON PLATELET FACTOR-3 AVAILABILITY.
    SPAET TH; CINTRON J
    Br J Haematol; 1965 May; 11():269-75. PubMed ID: 14282064
    [No Abstract]   [Full Text] [Related]  

  • 23. [The kaolin-activated recalcification test in the screening of coagulation disorders and in the control of anticoagulant therapy].
    Barberi G; Fiocca S
    Quad Sclavo Diagn; 1977 Jun; 13(2):167-75. PubMed ID: 594303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet and plasma Factor 13 (fibrin-stabilizing factor).
    Kiesselbach TH; Wagner RH
    Thromb Diath Haemorrh Suppl; 1967; 26():155-65. PubMed ID: 4965104
    [No Abstract]   [Full Text] [Related]  

  • 25. [Platelet factor 3 availability in patients affected by pancreatic diabetes (author's transl)].
    Gandolfo GM; Afeltra A; Amoroso A; Ferri GM
    Haematologica; 1974 Sep; 59(3):316-23. PubMed ID: 4218190
    [No Abstract]   [Full Text] [Related]  

  • 26. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
    Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
    Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet factor 3 (PF 3) and platelet factor 4 (PF 4) as a guide to platelet membrane structure.
    O'Brien JR
    Acta Med Scand Suppl; 1971; 525():87-8. PubMed ID: 5292111
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet factor 3: a simple assay technique.
    Saraya AK; Kasturi J; Kishan R
    Indian J Med Res; 1973 May; 61(5):676-83. PubMed ID: 4763948
    [No Abstract]   [Full Text] [Related]  

  • 29. PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.
    MATCHETT MO; INGRAM GI
    J Clin Pathol; 1965 Jul; 18(4):465-71. PubMed ID: 14318702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies of platelet factor-3 by the kaolin clotting time and thromboplastin generation time].
    Oki H; Takashima A
    Rinsho Byori; 1973 Jul; 21(7):621-6. PubMed ID: 4738067
    [No Abstract]   [Full Text] [Related]  

  • 31. The activity of platelet factor 4 in plasma of healthy and high risk newborns.
    Alebouyeh M; Unterharnscheidt W; Riegel K
    Z Kinderheilkd; 1974 Jan; 116(2):137-42. PubMed ID: 4816158
    [No Abstract]   [Full Text] [Related]  

  • 32. Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations.
    Ponschab M; Schöchl H; Gabriel C; Süssner S; Cadamuro J; Haschke-Becher E; Gratz J; Zipperle J; Redl H; Schlimp CJ
    Anaesthesia; 2015 May; 70(5):528-36. PubMed ID: 25866040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Platelet factor IV (antiheparin factor) and various disease states].
    Ulutin ON; Akman N
    Turk Tip Cemiy Mecm; 1967 Jan; 33(1):61-5. PubMed ID: 6066642
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosis.
    Dana B; Carvalho AC; Ellman L
    Am J Clin Pathol; 1976 Jun; 65(6):964-9. PubMed ID: 945687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidines.
    Slater SD; Turpie AG; Douglas AS; McNicol GP
    J Clin Pathol; 1972 May; 25(5):427-32. PubMed ID: 5046075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma factor XIII and platelet factor XIII in hyperlipaemia.
    Cucuianu MP; Miloszewski K; Porutiu D; Losowsky MS
    Thromb Haemost; 1976 Dec; 36(3):542-50. PubMed ID: 1037152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of platelet factor-3 by a modified prothrombin consumption test.
    Farská I; Pudlák P
    Scand J Haematol; 1967; 4(3):187-92. PubMed ID: 6048641
    [No Abstract]   [Full Text] [Related]  

  • 38. Acid phosphatases and platelet factor 3.
    Polásek J; Kubisz P
    Scand J Haematol; 1968; 5(5):390-400. PubMed ID: 4974194
    [No Abstract]   [Full Text] [Related]  

  • 39. [Methods of measurement of Willebrand activity on microtitration plates].
    Sultan Y; Rossi J
    Nouv Presse Med; 1977 Jan; 6(1):44-6. PubMed ID: 299940
    [No Abstract]   [Full Text] [Related]  

  • 40. Subcellular localization of the heparin-neutralizing factor in blood platelets.
    Da Prada M; Jakábová M; Lüscher EF; Pletscher A; Richards JG
    J Physiol; 1976 May; 257(2):495-502. PubMed ID: 950602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.